Sign in to continue:

Sunday, February 8th, 2026
Stock Profile: 8YY
8YY Logo

Embracing Future Holdings Limited (8YY)


📊 Statistics




💰 Dividend History


Current year to date yield: 0.00%

2022 — Total Amount: $0.000000 | Total Yield: 0.00%
Ex Date: 2022-11-07

Amount: -

Yield: -

Pay Date: -

Details: Ratio: 1:1



📅 SGX Earnings Announcements for 8YY


Date of Broadcast Title Financial Year Ended
2025-08-12 17:46 Half Yearly Results 2025/06/30
2025-02-28 23:18 Full Yearly Results 2024/12/31
2024-11-01 21:43 Third Quarter Results 2024/09/30
2024-08-13 19:12 Half Yearly Results 2024/06/30
2024-05-14 18:00 First Quarter Results 2024/03/31
2024-02-28 17:30 Full Yearly Results 2023/12/31
2023-11-14 17:36 Third Quarter Results 2023/09/30
2023-07-31 17:31 Half Yearly Results 2023/06/30


Embracing Future Holdings Limited (8YY)

Market: SGX | Currency: SGD

Address: 18 Howard Road

Embracing Future Holdings Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Japan, Hong Kong, Thailand, Malaysia, and the United States. It operates through Cancer, Infectious Diseases, and Laboratory Services segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 biochip that isolate the CTCs from leukocytes. It also provides laboratory services. The company was formerly known as Biolidics Limited Show more



📈 Embracing Future Holdings Limited Historical Chart




🧾 Recent Financial Statement Analysis


🔎 View more in SGX corporate News 🔎 View more in SGX Financial statements



📰 Related News & Research


Showing results matched by any of: 8YY, Embracing Future Holdings Limited, EFH Ltd, EFH SP, EMBRACING FUTURE HOLDINGS LT, EMBRACING FUTURE